Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Am J Transplant ; 16(4): 1160-72, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26689983

ABSTRACT

Organ damage and innate immunity during heart transplantation may evoke adaptive immunity with serious consequences. Because lymphatic vessels bridge innate and adaptive immunity, they are critical in immune surveillance; however, their role in ischemia-reperfusion injury (IRI) in allotransplantation remains unknown. We investigated whether the lymphangiogenic VEGF-C/VEGFR3 pathway during cardiac allograft IRI regulates organ damage and subsequent interplay between innate and adaptive immunity. We found that cardiac allograft IRI, within hours, increased graft VEGF-C expression and lymphatic vessel activation in the form of increased lymphatic VEGFR3 and adhesion protein expression. Pharmacological VEGF-C/VEGFR3 stimulation resulted in early lymphatic activation and later increase in allograft inflammation. In contrast, pharmacological VEGF-C/VEGFR3 inhibition during cardiac allograft IRI decreased early lymphatic vessel activation with subsequent dampening of acute and chronic rejection. Genetic deletion of VEGFR3 specifically in the lymphatics of the transplanted heart recapitulated the survival effect achieved by pharmacological VEGF-C/VEGFR3 inhibition. Our results suggest that tissue damage rapidly changes lymphatic vessel phenotype, which, in turn, may shape the interplay of innate and adaptive immunity. Importantly, VEGF-C/VEGFR3 inhibition during solid organ transplant IRI could be used as lymphatic-targeted immunomodulatory therapy to prevent acute and chronic rejection.


Subject(s)
Endothelial Cells/metabolism , Graft Rejection/metabolism , Heart Transplantation , Reperfusion Injury/metabolism , Vascular Endothelial Growth Factor Receptor-3/metabolism , Allografts , Animals , Endothelial Cells/pathology , Graft Rejection/pathology , Graft Survival/immunology , Inflammation/metabolism , Inflammation/pathology , Lymphangiogenesis , Mice , Mice, Inbred C57BL , Mice, Knockout , Rats , Reperfusion Injury/physiopathology , Tissue Donors , Vascular Endothelial Growth Factor C/metabolism
2.
Am J Transplant ; 15(8): 2075-84, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25932532

ABSTRACT

The major cause of death during the first year after heart transplantation is primary graft dysfunction due to preservation and ischemia-reperfusion injury (IRI). Angiopoietin-1 is a Tie2 receptor-binding paracrine growth factor with anti-inflammatory properties and indispensable roles in vascular development and stability. We used a stable variant of angiopoietin-1 (COMP-Ang1) to test whether ex vivo intracoronary treatment with a single dose of COMP-Ang1 in donor Dark Agouti rat heart subjected to 4-h cold ischemia would prevent microvascular dysfunction and inflammatory responses in the fully allogeneic recipient Wistar Furth rat. COMP-Ang1 reduced endothelial cell-cell junction disruption of the donor heart in transmission electron microscopy during 4-h cold ischemia, improved myocardial reflow, and reduced microvascular leakage and cardiomyocyte injury of transplanted allografts during IRI. Concurrently, the treatment reduced expression of danger signals, dendritic cell maturation markers, endothelial cell adhesion molecule VCAM-1 and RhoA/Rho-associated protein kinase activation and the influx of macrophages and neutrophils. Furthermore, COMP-Ang1 treatment provided sustained anti-inflammatory effects during acute rejection and prevented the development of cardiac fibrosis and allograft vasculopathy. These results suggest donor heart treatment with COMP-Ang1 having important clinical implications in the prevention of primary and subsequent long-term injury and dysfunction in cardiac allografts.


Subject(s)
Graft Rejection/prevention & control , Heart Transplantation , Recombinant Fusion Proteins/therapeutic use , Reperfusion Injury/prevention & control , Tissue Donors , Animals , Rats
3.
Am J Transplant ; 14(5): 1096-108, 2014 May.
Article in English | MEDLINE | ID: mdl-24708486

ABSTRACT

Transplant ischemia-reperfusion injury (Tx-IRI) and allograft dysfunction remain as two of the major clinical challenges after heart transplantation. We investigated the role of angiopoietin-2 (Ang2) in Tx-IRI and rejection using fully MHC-mismatched rat cardiac allografts. We report that plasma levels of Ang2 were significantly enhanced in the human and rat recipients of cardiac allografts, but not in the rat recipients of syngrafts, during IRI. Ex vivo intracoronary treatment of rat cardiac allografts with anti-Ang2 antibody before 4-h cold preservation prevented microvascular dysfunction, endothelial cell (EC) adhesion molecule expression and leukocyte infiltration, myocardial injury and the development of cardiac fibrosis and allograft vasculopathy. Recipient preoperative and postoperative treatment with anti-Ang2 antibody produced otherwise similar effects without effecting microvascular dysfunction, and in additional experiments prolonged allograft survival. Recipient preoperative treatment alone failed to produce these effects. Moreover, ex vivo intracoronary treatment of allografts with recombinant Ang2 enhanced Tx-IRI and, in an add-back experiment, abolished the beneficial effect of the antibody. We demonstrate that neutralization of Ang2 prevents EC activation, leukocyte infiltration, Tx-IRI and the development of chronic rejection in rat cardiac allografts. Our results suggest that blocking Ang2 pathway is a novel, clinically feasible, T cell-independent strategy to protect cardiac allografts.


Subject(s)
Angiopoietin-2/antagonists & inhibitors , Antibodies, Monoclonal/therapeutic use , Graft Rejection/prevention & control , Heart Transplantation , Postoperative Complications/prevention & control , Reperfusion Injury/prevention & control , Adult , Aged , Allografts , Angiopoietin-2/blood , Angiopoietin-2/immunology , Animals , Brain Death , Case-Control Studies , Chronic Disease , Female , Graft Rejection/etiology , Graft Rejection/metabolism , Graft Survival , Heart Diseases/surgery , Humans , Male , Middle Aged , Postoperative Complications/etiology , Postoperative Complications/metabolism , Rats , Reperfusion Injury/etiology , Reperfusion Injury/metabolism , Young Adult
4.
Am J Transplant ; 13(8): 2019-34, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23773358

ABSTRACT

Ischemia-reperfusion injury (IRI) after kidney transplantation may result in delayed graft function. We used rat renal artery clamping and transplantation models to investigate cholesterol-independent effects of clinically relevant single-dose peroral simvastatin treatment 2 h before renal ischemia on microvascular injury. The expression of HMG-CoA reductase was abundant in glomerular and peritubular microvasculature of normal kidneys. In renal artery clamping model with 30-min warm ischemia, simvastatin treatment prevented peritubular microvascular permeability and perfusion disturbances, glomerular barrier disruption, tubular dysfunction and acute kidney injury. In fully MHC-mismatched kidney allografts with 16-h cold and 1-h warm ischemia, donor simvastatin treatment increased the expression of flow-regulated transcription factor KLF2 and vasculoprotective eNOS and HO-1, and preserved glomerular and peritubular capillary barrier integrity during preservation. In vitro EC Weibel-Palade body exocytosis assays showed that simvastatin inhibited ischemia-induced release of vasoactive angiopoietin-2 and endothelin-1. After reperfusion, donor simvastatin treatment prevented microvascular permeability, danger-associated ligand hyaluronan induction, tubulointerstitial injury marker Kim-1 immunoreactivity and serum creatinine and NGAL levels, and activation of innate and adaptive immune responses. In conclusion, donor simvastatin treatment prevented renal microvascular dysfunction and IRI with beneficial effects on adaptive immune and early fibroproliferative responses. Further studies may determine potential benefits in clinical cadaveric kidney transplantation.


Subject(s)
Acute Kidney Injury/prevention & control , Graft Survival/drug effects , Immunity, Innate/drug effects , Kidney/drug effects , Microvessels/drug effects , Reperfusion Injury/prevention & control , Simvastatin/therapeutic use , Acute Kidney Injury/drug therapy , Acute Kidney Injury/metabolism , Animals , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Kidney/blood supply , Kidney/metabolism , Kidney Transplantation , Male , Rats , Rats, Inbred WF , Reperfusion Injury/drug therapy , Reperfusion Injury/metabolism
5.
Am J Transplant ; 13(3): 600-10, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23331861

ABSTRACT

Ischemia-reperfusion injury (IRI) induces hypoxia-inducible factor-1 (HIF-1) in the myocardium, but the consequences remain elusive. We investigated HIF-1 activation during cold and warm ischemia and IRI in rat hearts and cardiac syngrafts. We also tested the effect of HIF-α stabilizing prolyl hydroxylase inhibitor (FG-4497) on IRI or allograft survival. Ex vivo ischemia of the heart increased HIF-1α expression in a time- and temperature-dependent fashion. Immunohistochemistry localized HIF-1α to all cardiac cell types. After reperfusion, HIF-1α immunoreactivity persisted in smooth muscle cells and cardiomyocytes in the areas with IRI. This was accompanied with a transient induction of protective HIF-1 downstream genes. Donor FG-4497 pretreatment for 4 h enhanced IRI in cardiac allografts as evidenced by an increase in cardiac troponin T release, cardiomyocyte apoptosis, and activation of innate immunity. Recipient FG-4497 pretreatment for 4 h decreased infiltration of ED1(+) macrophages, and mildly improved the long-term allograft survival. In syngrafts donor FG-4497 pretreatment increased activation of innate immunity, but did not induce myocardial damage. We conclude that the HIF-1 pathway is activated in heart transplants. We suggest that pharmacological HIF-α preconditioning of cardiac allografts donors would not lead to clinical benefit, while in recipients it may result in antiinflammatory effects and prolonged allograft survival.


Subject(s)
Enzyme Inhibitors/pharmacology , Heart Transplantation , Heart/physiopathology , Hypoxia-Inducible Factor 1/metabolism , Ischemic Preconditioning , Procollagen-Proline Dioxygenase/antagonists & inhibitors , Reperfusion Injury/prevention & control , Animals , Apoptosis/drug effects , Biomarkers/analysis , Inflammation/diagnosis , Inflammation/metabolism , Macrophages/metabolism , Macrophages/pathology , Male , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/pathology , Rats , Rats, Inbred WF , Reperfusion Injury/metabolism , Reperfusion Injury/pathology , Transplantation, Homologous
6.
Euro Surveill ; 14(49)2009 Dec 10.
Article in English | MEDLINE | ID: mdl-20003905

ABSTRACT

We describe a cluster of norovirus outbreaks affecting about 200 people in Southern Finland in September and October 2009. All outbreaks occurred after consumption of imported raspberries from the same batch intended for the catering sector. Human norovirus genotype GI.4 was found in frozen raspberries. The berries were served in toppings of cakes in separate catering settings or mixed in curd cheese as a snack for children in a daycare center. The relative risk for consumption of the berry dish was 3.0 (p

Subject(s)
Caliciviridae Infections/epidemiology , Disease Outbreaks/statistics & numerical data , Food Contamination/statistics & numerical data , Fruit/microbiology , Gastroenteritis/epidemiology , HIV Infections/epidemiology , Norovirus , Cluster Analysis , Female , Finland/epidemiology , Freezing , Humans , Incidence , Male , Population Surveillance/methods , Risk Assessment , Risk Factors
7.
Transplant Proc ; 38(10): 3271-3, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17175246

ABSTRACT

BACKGROUND: In chronic rejection, parenchymal fibrosis and cardiac allograft vasculopathy (CAV) characterized by neointimal growth are the leading causes of graft loss for heart transplant recipients. During alloimmune responses a variety of cytokines, adhesion proteins, and growth factors, such as platelet-derived growth factor (PDGF), are up-regulated. The PDGF family (AA, AB, BB, CC, DD), which acts mainly on connective tissue cells, is considered to be a potent mitogenic and chemotactic factor for fibroblasts and vascular smooth muscle cells. In this study, we evaluated the effects of PDGF ligands in chronic rejection. METHODS: Heterotopic heart transplantations were performed between fully major histocompatability complex-mismatched Dark Agouti to Wistar Furth rats receiving cyclosporine immunosuppression. Allograft coronary arteries were perfused with a recombinant adeno-associated virus (AAV) encoding enhanced green fluorescence protein (EGFP) as a control gene or PDGF-A, -B, -C, -D. Allografts were harvested at 100 days for morphometric analysis of CAV and fibrosis. RESULTS: AAV-mediated transgene expression was detected by EGFP immunoreactivity across the graft section (at 100 days) in AAV EGFP-perfused allografts. AAV PDGF-A, -C, and -D perfusion resulted in accelerated CAV and fibrosis. In contrast, AAV PDGF-B perfusion did not induce arteriosclerotic changes or fibrosis in cardiac allografts. CONCLUSIONS: AAV PDGF-A, -C, and -D overexpression accelerated the development of chronic rejection, whereas PDGF-B did not. Our results suggested that more targeted therapy with monoclonal antibodies blocking the active sites of PDGF-A, -C, and -D may produce beneficial effects on heart transplant survival.


Subject(s)
Coronary Disease/pathology , Heart Transplantation/pathology , Platelet-Derived Growth Factor/genetics , Postoperative Complications/pathology , Animals , Dependovirus/genetics , Fibrosis , Rats , Rats, Inbred Strains , Rats, Inbred WF , Transplantation, Homologous , Vascular Diseases
8.
Transplant Proc ; 38(10): 3372-3, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17175275

ABSTRACT

Hypoxia plays an integral part in cardiac transplantation as prolonged graft preservation is an individual risk factor for the development of cardiac allograft vasculopathy (CAV). In this study we characterized the role of hypoxia-inducible factor-1 (HIF-1) during prolonged graft preservation, ischemia-reperfusion (I/R), acute rejection, and chronic rejection. Heart transplantations were performed from Dark Agouti (DA) to Wister-Furth (allo) or DA to DA (syn) rats, without immunosuppression (acute rejection model, harvested at day 5) or with cyclosporine (chronic rejection model, harvested at day 60). To study the effect of preservation on HIF-1 regulation, normal DA hearts were subjected to different cold ischemia times with or without 45 minutes of additional warm ischemia. The role of I/R was studied by harvesting syngrafts at different time points after reperfusion. Real-time reverse-transcriptase polymerase chain reaction quantified total HIF-1 mRNA, while enzyme-linked immunosorbent assay and immunohistochemistry quantified and localized HIF-1 protein. Our results show that HIF-1 nuclear immunoreactivity is increased during graft preservation and I/R leads to loss of nuclear HIF-1 immunoreactivity. Acute rejection induced HIF-1 in mRNA level. Our findings thus indicated that HIF-1 is activated during transplantation and suggested that manipulation of the HIF-1 pathway might reveal new therapeutic options to manage CAV.


Subject(s)
Graft Rejection/physiopathology , Heart Transplantation/physiology , Hypoxia-Inducible Factor 1/genetics , Animals , Cell Hypoxia , Gene Expression Regulation , Heart Transplantation/immunology , Immunohistochemistry , Organ Preservation , Rats , Rats, Inbred Strains , Rats, Inbred WF , Reverse Transcriptase Polymerase Chain Reaction , Transplantation, Homologous , Transplantation, Isogeneic
9.
Arch Virol ; 149(9): 1867-75, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15593427

ABSTRACT

Blackcurrant reversion virus (BRV) belongs in the subgroup c of nepoviruses. The 3' NTRs of RNAs 1 and 2 of BRV are 1360 and 1363 nucleotides long, respectively, and highly similar (94.8%). In this study we have compared the sequences of the 3' NTRs of ten BRV isolates, originating from different geographic regions or hosts. All deduced sequences were 94.1-98.8% identical with each other, and with the previously deduced 3' NTR sequences of RNAsl and 2 of the type isolate. The proceeding 480 nucleotides of the CP coding region were 86.9-97.9% identical between the same isolates.


Subject(s)
3' Untranslated Regions , Conserved Sequence , Nepovirus/genetics , Base Sequence , Capsid Proteins/genetics , Molecular Sequence Data , Nepovirus/isolation & purification , Phylogeny , Sequence Alignment , Sequence Homology, Amino Acid , Sequence Homology, Nucleic Acid
10.
Opt Express ; 8(13): 682-7, 2001 Jun 18.
Article in English | MEDLINE | ID: mdl-19421258

ABSTRACT

Liquid-phase deposition of sol-gel method derived hybrid glass materials is utilized for fabrication of UV-light-sensitive thin films. The hybrid glass material undergoes a surface-relief deformation when exposed to UV light. The observed deformation phenomenon is in the form of a physical expansion of the exposed areas. The UV light induced surface expansion of the hybrid glass film was used to fabricate near-sinusoidal diffraction gratings with periods of 24 microm, 18 microm, 12 microm, and 9 microm. The maximum deformation when the material was patterned as a diffraction grating was 0.685 microm. The hybrid glass material features an index of refraction of 1.52 at 632.8 microm, rms surface roughness of 2.2 +/- 0.8 microm after processing, and extinction coefficients of 1.2 x 10-3 microm-1 and 0.47 x 10-3 mm-1 at wavelengths of 633 nm and 1550 nm, respectively.

11.
Carbohydr Res ; 328(1): 17-36, 2000 Aug 18.
Article in English | MEDLINE | ID: mdl-11005573

ABSTRACT

An expeditious approach to various protected hexoses has been developed by the use of the Sharpless catalytic asymmetric dihydroxylation reaction. Applying the Sharpless catalytic asymmetric dihydroxylation reaction on vinylfuran, diols with high enantioexcess are produced. The resulting diols can be stereoselectively transformed into either protected D- or L-mannose in five steps and approximately 39% yield from furfural. Similarly, both D- and L-talose and gulose have been synthesized in 19% overall yields, respectively. Using a modified strategy, both protected D- and L-gulo- and allo-sugar-delta-lactones were synthesized in eight steps and approximately 20%, overall yield from furfural.


Subject(s)
Hexoses/chemical synthesis , Furaldehyde/chemistry , Hydroxylation , Lactones/chemical synthesis , Mannose/chemical synthesis , Stereoisomerism
12.
J Oral Pathol Med ; 29(7): 299-302, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10947244

ABSTRACT

A population-based survey was conducted in 35 municipalities in Northern Finland to assess the incidence of lip cancer as well as the patient and tumour characteristics in cases diagnosed between 1983 and 1997. A total of 96 new patients emerged. The age-standardised incidence (per 100,000 years) of lip cancer in men decreased from 4.8 in 1983-1987 to 1.4 in 1993-1997. The incidences in women were 0.30 to 0.36, respectively. The median age of the patients increased from 66 to 73 years through the years. Overall, 90% of the patients had at least one of the known risk factors, namely rural domicile, outdoor occupation or smoking. The median duration of symptoms also remained the same, as did the median size and location of the tumour at diagnosis. In contrast, spread to regional lymph nodes became rare during the period.


Subject(s)
Lip Neoplasms/epidemiology , Age Factors , Aged , Female , Finland/epidemiology , Humans , Incidence , Male , Middle Aged , Occupations , Risk Factors , Rural Health , Sex Ratio , Smoking
13.
J Biol Chem ; 275(12): 8936-44, 2000 Mar 24.
Article in English | MEDLINE | ID: mdl-10722741

ABSTRACT

Type XIII collagen is a type II transmembrane protein predicted to consist of a short cytosolic domain, a single transmembrane domain, and three collagenous domains flanked by noncollagenous sequences. Previous studies on mRNAs indicate that the structures of the collagenous domain closest to the cell membrane, COL1, the adjacent noncollagenous domain, NC2, and the C-terminal domains COL3 and NC4 are subject to alternative splicing. In order to extend studies of type XIII collagen from cDNAs to the protein level we have produced it in insect cells by means of baculoviruses. Type XIII collagen alpha chains were found to associate into disulfide-bonded trimers, and hydroxylation of proline residues dramatically enhanced this association. This protein contains altogether eight cysteine residues, and interchain disulfide bonds could be located in the NC1 domain and possibly at the junction of COL1 and NC2, while the two cysteine residues in NC4 are likely to form intrachain bonds. Pepsin and trypsin/chymotrypsin digestions indicated that the type XIII collagen alpha chains form homotrimers whose three collagenous domains are in triple helical conformation. The thermal stabilities (T(m)) of the COL1, COL2, and COL3 domains were 38, 49 and 40 degrees C, respectively. The T(m) of the central collagenous domain is unusually high, which in the light of this domain being invariant in terms of alternative splicing suggests that the central portion of the molecule may have an important role in the stability of the molecule. All in all, most of the type XIII collagen ectodomain appears to be present in triple helical conformation, which is in clear contrast to the short or highly interrupted triple helical domains of the other known collagenous transmembrane proteins.


Subject(s)
Collagen/metabolism , Cystine , Membrane Proteins/metabolism , Procollagen-Proline Dioxygenase/metabolism , Animals , Antibody Specificity , Chymotrypsin/pharmacology , Collagen/chemistry , Collagen/genetics , Collagen/immunology , Hot Temperature , Humans , Hydroxylation , Membrane Proteins/chemistry , Membrane Proteins/genetics , Membrane Proteins/immunology , Nucleopolyhedroviruses/genetics , Protein Denaturation , Protein Structure, Quaternary , Protein Structure, Secondary , Recombinant Proteins/chemistry , Recombinant Proteins/immunology , Recombinant Proteins/metabolism , Spodoptera/cytology , Trypsin/pharmacology
14.
Biophys J ; 77(2): 1159-67, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10423461

ABSTRACT

We identify objects from their visually observable morphological features. Automatic methods for identifying living objects are often needed in new technology, and these methods try to utilize shapes. When it comes to identifying plant species automatically, machine vision is difficult to implement because the shapes of different plants overlap and vary greatly because of different viewing angles in field conditions. In the present study we show that chlorophyll a fluorescence, emitted by plant leaves, carries information that can be used for the identification of plant species. Transient changes in fluorescence intensity when a light is turned on were parameterized and then subjected to a variety of pattern recognition procedures. A Self-Organizing Map constructed from the fluorescence signals was found to group the signals according to the phylogenetic origins of the plants. We then used three different methods of pattern recognition, of which the Bayesian Minimum Distance classifier is a parametric technique, whereas the Multilayer Perceptron neural network and k-Nearest Neighbor techniques are nonparametric. Of these techniques, the neural network turned out to be the most powerful one for identifying individual species or groups of species from their fluorescence transients. The excellent recognition accuracy, generally over 95%, allows us to speculate that the method can be further developed into an application in precision agriculture as a means of automatically identifying plant species in the field.


Subject(s)
Chlorophyll/chemistry , Plants/chemistry , Plants/classification , Biophysical Phenomena , Biophysics , Chlorophyll/radiation effects , Chlorophyll A , Fluorescence , Models, Biological , Pattern Recognition, Automated , Photosynthesis , Plants/radiation effects , Species Specificity
15.
Brain ; 120 ( Pt 10): 1723-37, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9365366

ABSTRACT

Four-hundred and fifty-one blood samples from Scandinavian patients with motor neuron disease were analysed for mutations in the CuZn-superoxide dismutase gene. Forty-one (9.6%) of the 427 patients with the amyotrophic lateral sclerosis (ALS) form of the disease were found to have a disease-associated mutation, and 14 of these patients were apparently sporadic cases. A mutation was found in 12 of the 51 families with recognized familial ALS. The five different mutations found (Ala4Val, Val14Gly, Asp76Tyr, Asp90Ala, Gly127insTGGG) have different genetic characteristics and are associated with very variable phenotypes spanning from rapidly progressing disease with only lower motor neuron signs to very slowly progressing disease with both the upper and lower motor neuron systems affected. The patients showed different sites of onset, though the progressive bulbar palsy form of the disease appears to be rare among patients with a CuZn-superoxide dismutase mutation. The progression of motor signs and symptoms followed the same basic pattern in patients with different mutations. Extra-motor system symptoms were frequent among patients with a CuZn-superoxide dismutase mutation. The results suggest that patients with mutations in the CuZn-superoxide dismutase gene constitute one disease entity. The Val14Gly and Asp76Tyr mutations have not been reported before, and the latter is the first mutation to be found in exon 3 of the CuZn-superoxide dismutase gene.


Subject(s)
Genetic Variation/genetics , Motor Neuron Disease/genetics , Mutation , Superoxide Dismutase/genetics , Adult , Aged , Aged, 80 and over , Amyotrophic Lateral Sclerosis/genetics , Bulbar Palsy, Progressive/genetics , Female , Humans , Male , Middle Aged , Pedigree , Phenotype , Scandinavian and Nordic Countries
16.
Brain ; 119 ( Pt 4): 1153-72, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8813280

ABSTRACT

We describe 36 patients (six were apparently sporadic cases and 30 were cases from nine families) with amyotrophic lateral sclerosis (ALS) characterized by a distinct phenotype associated with homozygosity for an Asp90Ala mutation in the CuZn-superoxide dismutase gene. The presenting motor manifestation in all patients was paresis in the legs, with slow progression to the upper extremities and finally to the bulbar muscles. The age of ALS onset varied from 20 to 94 years, with a mean of 44 years. Mean survival time was 13 years for the 11 deceased patients. However, this is probably biased and untypical (low) when compared with the disease duration in the surviving patients, and when considering other medical complications in the deceased patients. The rate of progression was highly variable, even within families. All patients showed signs of involvement of both upper and lower motor neurons. Other neurological features included painful muscle spasms and paraesthesiae in the lower extremities. Two-thirds of patients experienced difficulty with micturition. Electrophysiological studies confirmed the slow progression and spatial distribution of clinical symptoms in the peripheral motor system. Furthermore, [corrected] potentials evoked by transcranial magnetic stimulation (MEP) were compared with those evoked by cervical or lumbosacral electrical stimulation and often revealed marked slowing of transmission in central motor pathways. In Sweden and Finland ALS patients homozygous for the Asp90Ala mutation constitute a phenotypically characteristic subset of motor neuron disease.


Subject(s)
Amyotrophic Lateral Sclerosis/genetics , Superoxide Dismutase/genetics , Adult , Age Distribution , Aged , Amyotrophic Lateral Sclerosis/physiopathology , Female , Humans , Male , Middle Aged , Motor Neuron Disease/genetics , Prognosis
19.
Nat Genet ; 10(1): 61-6, 1995 May.
Article in English | MEDLINE | ID: mdl-7647793

ABSTRACT

Recent reports have shown heterozygosity for some twenty different mutations in the CuZn-superoxide dismutase (CuZn-SOD) gene in familial amyotrophic lateral sclerosis (FALS), and analysed samples from patients have shown decreased enzymic activity. Here we report homozygosity for an exon 4 mutation, Asp90Ala in fourteen patients among four unrelated ALS families and four apparently sporadic ALS patients from Sweden and Finland. The erythrocyte CuZn-SOD activity is essentially normal. Our findings suggest that this CuZn-SOD mutation causes ALS by a gain of function rather than by loss, and that the Asp90Ala mutation is less detrimental than previously reported mutations.


Subject(s)
Amyotrophic Lateral Sclerosis/genetics , Homozygote , Mutation , Superoxide Dismutase/genetics , Adult , Aged , Base Sequence , Erythrocytes/metabolism , Exons , Female , Humans , Male , Middle Aged , Molecular Sequence Data , Pedigree , Polymorphism, Single-Stranded Conformational , Superoxide Dismutase/metabolism
20.
Biochem Biophys Res Commun ; 189(1): 424-9, 1992 Nov 30.
Article in English | MEDLINE | ID: mdl-1449493

ABSTRACT

The nucleotide sequence of a cDNA encoding the proenzyme of mouse S-adenosylmethionine decarboxylase (AdoMetDC) including 257 nucleotides of the 5' untranslated region has been determined. Comparison of the nucleotide sequence of the mouse 5' untranslated region with those of other mammals shows it to be highly conserved. The 52 nucleotides upstream from the translation initiation codon are identical in human, rat, bovine and mouse. The polyamines, spermidine and spermine, have been shown to inhibit AdoMetDC mRNA translation. An RNA gel retardation assay demonstrated that a cytoplasmic extract from mouse brain forms an RNA-protein complex with the completely conserved 5' untranslated sequence and that the complex formation is highly dependent on the presence of spermine. Crosslinking by UV irradiation shows that the complex contains a 39-kDa protein interacting with the 5' untranslated sequence. These data demonstrate spermine-dependent specific protein binding to a highly conserved 5' untranslated region of an mRNA translationally regulated by polyamines.


Subject(s)
Adenosylmethionine Decarboxylase/genetics , Brain/enzymology , Nerve Tissue Proteins/metabolism , RNA, Messenger/metabolism , Adenosylmethionine Decarboxylase/metabolism , Animals , Base Sequence , Cattle , Cloning, Molecular , Cytosol/metabolism , DNA/genetics , DNA/isolation & purification , Enzyme Precursors/genetics , Gene Library , Humans , Mice , Molecular Sequence Data , Nerve Tissue Proteins/isolation & purification , Polyamines/pharmacology , Protein Binding , RNA, Messenger/genetics , Rats , Sequence Homology, Nucleic Acid , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...